Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Round-up of EU Monitor news
The European Association of Hospital Pharmacists (EAHP) produces a weekly email of the top European policy developments and other news of interest to hospital pharmacists called the EU Monitor. Below, EAHP Policy and Advocacy Officer Richard Price presents some recent highlights.
Cyprus Presidency outlines seven health priorities
EAHP EU Monitor 20 July 2012
The 6-month Cypriot Presidency of the Council of Ministers has outlined seven health policy priorities including clinical trials, pharmacovigilance and medical device regulation. A newly published web page of the Cyprus Presidency lists the following seven priorities for health:
Healthy ageing across the lifecycle
A legislative proposal on serious cross-border threats to health
Organ donation and transplantation
Transparency of measures regulating the pricing of medicinal products for human use
Medical device regulation
On healthy ageing the Cyprus Presidency will ‘further develop work in the area of healthy ageing by collecting evidence and highlighting best practices which prove that healthy ageing is a matter of continuous process that requires the implementation of health promotion and disease prevention programmes. In this effort, key elements will be, among others, the multidisciplinary approaches involving both individuals and their community, and their application throughout the lifecycle, from early stages of life until the late years.’
On cross-border health threats the Cyprus Presidency will advance national governments’ discussions on the Commission's December 2011 legislative proposal on the subject and promote the regional dimension of health security and capacity building. The Commission's …
Collaborator Arnold Vulto.
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.
Data sharing statement Further information is available from the corresponding author at .